RUNX1 and leukemia: Monitoring RUNX1-FPD patients by sequencing panels to detect clonal hematopoiesis and/or alterations by variant allele fractions of already known variants may offer the opportunity to intervene at the pre-leukemic stage, prior to the appearance of overt MDS or frank leukemia.